0001415889-23-008241.txt : 20230517 0001415889-23-008241.hdr.sgml : 20230517 20230517210625 ACCESSION NUMBER: 0001415889-23-008241 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230516 FILED AS OF DATE: 20230517 DATE AS OF CHANGE: 20230517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dhingra Kapil CENTRAL INDEX KEY: 0001456849 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39200 FILM NUMBER: 23933539 MAIL ADDRESS: STREET 1: 39 BLISS AVENUE CITY: TENAFLY STATE: NJ ZIP: 07670 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Black Diamond Therapeutics, Inc. CENTRAL INDEX KEY: 0001701541 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MAIN STREET, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-417-5868 MAIL ADDRESS: STREET 1: ONE MAIN STREET, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Aset Therapeutics, Inc. DATE OF NAME CHANGE: 20170321 4 1 form4-05182023_010514.xml X0407 4 2023-05-16 0001701541 Black Diamond Therapeutics, Inc. BDTX 0001456849 Dhingra Kapil C/O BLACK DIAMOND THERAPEUTICS, INC. ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 true false false false 0 Stock Option (Right to Buy) 1.82 2023-05-16 4 A 0 16500 0 A 2033-05-15 Common Stock 16500 16500 D The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) May 16, 2024 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date. /s/ Brent Hatzis-Schoch, Attorney-in-Fact 2023-05-17